GSK to acquire Sierra Oncology for US $1.9bn
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
Dr. Mansukh Mandaviya launches a quarterly report on AB-HWCs, Guidelines on Human resources for health, Public Health Management Cadre’ Guidance for implementation and Indian Public Health Standards Guidelines; interacts with healthcare workers from across the country
First of its kind interactive concept store ‘Brilliant Sound Galaxy (BSG)’ in the capital city
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
The peptide-based vaccine induces a t cell-dependent response
Subscribe To Our Newsletter & Stay Updated